Cytokines in B-Cell Chronic Lymphocytic Leukemia

References

• Foa R., Fierro M. T., Giovarelli M., Lusso P., Benetton G., Bonferroni M., Forni G. Immunoregulatory T-cell defects in B-cell chronic lymphocytic leukemia: cause or consequence of the disease? The contributory role of decreased availability of interleukin 2 (IL-2). Blood Cells. 1987; 12: 399–42
   PubMedGoogle Scholar
• Ayanlar-Batuman O., Ebert E., Hauptman S. P. Defective interleukin-2 production and responsiveness by T cells in patients with chronic lymphocytic leukemia of B cell variety. Blood 1986; 67: 279–84
   PubMed Web of Science ®Google Scholar
• Foa R., Giovarelli M., Jemma C., Fierro M. T., Lusso P., Ferrando M. L., Lauria F., Forni G. Interleukin 2 (IL2) and interferon-γ production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL2 is absorbed by the neoplastic B cell population. Blood 1985; 66: 614–19
   PubMed Web of Science ®Google Scholar
• Alvareze de Mon M., Casas J., Laguna R., Toribio M. L., De Landazuri M. O., Durantez A. Lymphokine induction of NK-like cytotoxicity in T cells from B-CLL. Blood 1986; 67: 228–32
   PubMed Web of Science ®Google Scholar
• Platsoucas C. D., Fernandes G., Gupta S. L., Kempin S., Clarkson B., Good R. A., Gupta S. Defective spontaneous and antibody-dependent cytotoxicity mediated by E-rosette-positive and E-rosette-negative cells in untreated patients with chronic lymphocytic leukemia. Augmentation by in vitro treatment with interferon. Journal of Immunology 1980; 125: 1216–23
   PubMed Web of Science ®Google Scholar
• Foa R., Lauria F., Lusso P., Giubellino M. C., Fierro M T., Ferrando M. L., Raspadori D., Matera L. Discrepancy between phenotypic and functional features of natural killer T-lymphocytes in B-cell chronic lymphocytic leukemia. British Journal of Haematology 1984; 58: 509–16
   PubMed Web of Science ®Google Scholar
• Lantz O., Grillot-Courvalin C., Schmitt C., Fermand J-P., Brouet J-C. Interleukin 2-induced proliferation of leukemic human B cells. Journal of Experimental Medicine 1985; 161: 1225–30
   PubMed Web of Science ®Google Scholar
• Giovarelli M., Foa R., Benetton G., Lusso P., Fierro M. T., Forni G. Release of interleukin-2-like material by B-chronic lymphocytic leukemia cells. An autocrine or paracrine model of production and utilization?. Leukemia Research 1988; 12: 201–9
   PubMed Web of Science ®Google Scholar
• Foa R., Giovarelli M., Fierro M. T., Bonferroni M., Forni G. Autocrine or paracrine models of cytokine production and utilization in B-cell chronic lymphocytic leukemia. Nouvelle Revue Francaise d'Hematologie 1988; 30: 339–41
   PubMedGoogle Scholar
• Foa R., Fierro M. T., Raspadori D., Bonferroni M., Cardona S., Guarini A., Gillio Tos A., Francia di Celle P., Cesano A., Matera L., Lauria F., Gavosto F. Lymphokine activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogenic and autologous LAK effectors. Blood 1990; 76: 1349–54
   PubMed Web of Science ®Google Scholar
• Defrance T., Vanbervliet B., Aubry J-P., Banchereau J. Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2. Journal of Experimental Medicine 1988; 168: 1321–37
   PubMed Web of Science ®Google Scholar
• Karray S., Defrance T., Merle-Beral H., Banchereau J., Debre P., Galanaud P. Interleukin-4 counteracts the interleukin 2-induced proliferation of monoclonal B cells. Journal of Experimental Medicine 1988; 168: 85–94
   PubMed Web of Science ®Google Scholar
• Kishimoto T. The biology of Interleukin-6. Blood 1989; 74: 1–10
   PubMed Web of Science ®Google Scholar
• Morabito F., Prasthofer E. F., Dunlap N. E., Grossi C. E., Tilden A. B. Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin 1. Blood 1987; 70: 1750–7
   PubMed Web of Science ®Google Scholar
• Biondi A., Rossi V., Bassan R., Barbui T., Bettoni S., Sironi M., Mantovani A., Rambaldi A. Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. Blood 1989; 73: 1279, 84
   PubMed Web of Science ®Google Scholar
• Namen A. E., Schmierer A. E., March C. J., Overell R. W., Park L. S., Urdal D. L., Mochizuki D. Y. B cell precursor growth promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. Journal of Experimental Medicine 1988; 167: 988–1002
   PubMed Web of Science ®Google Scholar
• Touw I., Pouwels K., van Agthoven T., van Gurp R., Budel L., Hoogerbrugge H., Delwel R., Goodwin R., Namen A., Lowenberg B. Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. Blood 1990; 75: 2097–101
   PubMed Web of Science ®Google Scholar
• Foa R., Massaia M., Cardona S., Gillio Tos A., Bianchi A., Attisano C., Guarini A., Francia di Celle P., Fierro M. T. Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease. Blood 1990; 76: 393–400
   PubMed Web of Science ®Google Scholar
• Hahn T., Kusminsky G., Bassous L., Berrebi A. Tumor necrosis factor production in B cell chronic lymphocytic leukemia. Leukemia & Lymphoma 1991; 4: 117–21
   PubMed Web of Science ®Google Scholar
• Digel W., Schoniger W., Stefanic M., Janssen H., Buck C., Schmid M., Raghavachar A., Porzsolt F. Receptors for tumor necrosis factor on neoplastic B cells from chronic lymphocytic leukemia are expressed in vitro but not in vivo. Blood 1990; 76: 1607–71
   PubMed Web of Science ®Google Scholar
• Cordingley F. T., Bianchi A., Hoffbrand A. V., Reittie J. E., Heslop H. E., Vyakarnam A., Turner M., Meager A., Brenner M. K. Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet 1988; 1: 969–71
   PubMed Web of Science ®Google Scholar
• Digel W., Stefanic M., Schoniger W., Buck C., Raghavachar A., Frickhofen N., Heimpel H., Porzsolt F. Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood 1989; 73: 1242–6
   PubMed Web of Science ®Google Scholar
• Taylor C. W., Grogan T. M., Salmon S. E. Effects of interleukin-4 on the in vitro growth of human lymphoid and plasma cell neoplasms. Blood 1990; 75: 1114–8
   PubMed Web of Science ®Google Scholar